Sanofi wins first FDA approval for neurological symptoms of Gaucher disease
The FDA approved Sanofi's Infilbray, a brain-penetrating small molecule that is the first therapy cleared in the US to treat the neurological symptoms of Gaucher disease type 3.
·3 sources